Lin Liu, PhD joins ACTRI as the director of the Biostatistics, Epidemiology, and Research Design (BERD) unit, a joint position with the Herbert Wertheim School of Public Health (HWSPH). This new service core provides high quality biostatistics consultation, routine analytical services, and development of sophisticated novel biostatistical methods.
"Translational researchers need to understand and use statistical methods to design and analyze clinical studies in order to support state-of-the-art rigorous and reproducible research," says Liu. "We will help address these needs, in close integration with the UCSD School of Public Health Division of Biostatistics and Bioinformatics, serving as a point of entry for biostatistical consultation, collaboration, and training."
Liu came to UC San Diego in 2003 and worked her way from a staff to an academic position as a project scientist and then the professor track. Liu is currently an associate professor in the Division of Biostatistics and Bioinformatics at HWSPH. Her statistical methodology expertise is in designing and validating large-scale studies using electronic health records (EHR), and in prognostic modeling for risk factors in cancer. She has also worked on development of efficient methodologies to identify minimum effective dose in dose-response and toxicity studies and to analyze longitudinal HIV viral load data. An active collaborative biostatistician, she has published articles about HIV, cancer, gastroenterology, stroke, hypertension, infectious disease epidemiology, sleep apnea, psychiatric disorders, telemedicine, and other areas. Liu is a key faculty statistician for Moores Cancer Center with a focus on colorectal and prostate cancer research. She is also the director of the Master of Biostatistics Program, mentoring undergraduates, graduate students, and postdoctoral fellows.
Liu has experience training junior biostatisticians and early career physician-investigators as part of her role as the lead statistician for VA Health Services Research & Development (HSR&D). She is also Data and Safety Monitoring Board Chairperson for two Phase II clinical trials funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
"I am thrilled that Dr. Lin Liu has agreed to lead BERD as its director," says Mike Hogarth, MD, ACTRI's director of Biomedical Informatics. "She is an experienced biostatistician with a excellent track record of organizing effective biostatistics services for investigators. I look forward to realizing her vision for BERD, which will position UCSD exceptionally well for continued success in clinical research."
Liu begins as director of BERD in October 2021 and plans to hit the ground running. "Along with the rest of the ACTRI, I am looking forward to taking initiative in providing the UCSD research community with broader and easier access to professional biostatistical support and collaboration," she says.
In her free time, Liu enjoys hiking, making podcasts, and watching ballet performances.